Skip to main content
Caplight Logo









Fertilis

Fertilis

Private
AdelaideHealthcare & Life Scienceshttps://fertil.is

Last Round

Series A

Nov 8, 2023

Total Funding Raised

$2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Fertilis operates in Healthcare & Life Sciences and is based in Adelaide. Its latest recorded funding round was a Seed round in January 2022.

Fertilis is a medical technology company that develops micro-medical devices to automate and standardize in vitro fertilization (IVF) workflows.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, 3D Printing, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Fertilis Comparables

Compare Fertilis with similar companies based on industry and business-model similarity.

Fertilis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
IVFmicro
87%
Overture Life
83%
Conceivable Life Sciences
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Fertilis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 8, 2023
SeedJan 25, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Roger Yerramsetti

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Fertilis Investors

Notable investors and investment history

Fertilis investors
InvestorRounds
Horizons VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 1957% MoM, from 28 to 576.

  • Mar 1, 2026

    Monthly visitors increased 41% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Fertilis Filings

Explore SEC and related filing metadata, where available.

Fertilis filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Fertilis's valuation, stock price, and market status.

Is Fertilis a public or private company?

Fertilis is a private company.

What is the current stock price of Fertilis?

Fertilis is a private company, so its shares have no public market price. Caplight tracks Fertilis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Fertilis worth (valuation)?

Valuation information for Fertilis is not publicly available.

Can I buy Fertilis stock?

Fertilis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Fertilis's last funding round?

Fertilis's most recent funding round was Series A on November 8, 2023.

Who are the main investors in Fertilis?

Key investors in Fertilis include Horizons Ventures.

Will Fertilis IPO soon?

No public IPO plans have been announced for Fertilis.

How can I track Fertilis secondary market activity?

Caplight tracks bids, offers, and trades in Fertilis's shares on secondary markets.

Firmographic Details

HeadquartersAdelaide
Employee Range13
Year Founded2019
Last FundingNov 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?